Ezetimibe Improves Rosuvastatin Effects on Inflammation and Vascular Endothelial Function in Acute Coronary Syndrome Patients Undergoing PCI
Background. Little is known of the acute effects of ezetimibe in patients with acute coronary syndrome (ACS) undergoing PCI. We investigated whether ezetimibe improves inflammation and vascular endothelial function in patients with ACS undergoing PCI. Methods. We randomized 171 patients with ACS und...
Saved in:
Main Authors: | Changqing Sun, Wuyang Zheng, Ling Liang, Zuheng Liu, Wenchao Sun, Rong Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Interventional Cardiology |
Online Access: | http://dx.doi.org/10.1155/2021/2995602 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Evidence Evaluation on the Lipid Profile, Therapeutic Goals, and Safety of the Fixed-Dose Combination of Rosuvastatin/Ezetimibe (Trezete®) in Dyslipidemia Patients
by: Joel Rodríguez-Saldaña, et al.
Published: (2022-01-01) -
Spectrophotometric Determination of Ezetimibe
by: P. Baby Sudha Lakshmi, et al.
Published: (2010-01-01) -
Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension
by: Carmine Savoia, et al.
Published: (2011-01-01) -
Ezetimibe: An Unusual Suspect in Angioedema
by: Tiffany Lu, et al.
Published: (2020-01-01) -
Comparative Effectiveness of Rosuvastatin Versus Atorvastatin in Acute Ischemic Stroke Treatment
by: Joon‐Tae Kim, et al.
Published: (2025-02-01)